Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2008-05-14 AGM Information
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
2007年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled '2007 年年度股东大会 会议资料' which translates to '2007 Annual General Meeting (AGM) Materials'. It contains detailed agenda items, reports, and proposals to be discussed and voted on during the AGM held on May 16, 2008. The content includes the board of directors' work report, independent directors' report, financial statements for 2007, profit distribution plan, appointment of auditors, annual report and summary, supervisory board report, adjustments to supervisory and director allowances, and a proposal to change the company name. The document is comprehensive and appears to be the actual materials presented at the AGM rather than a brief announcement or a report publication notice. It includes detailed financial data, governance reports, and management discussions typical of AGM presentation materials. Therefore, the document fits the category of AGM Information (AGM-R).
2008-05-14 Chinese
第六届监事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions from the sixth meeting of the sixth supervisory board of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It includes approval of the 2008 first quarter report, changes in supervisory board members, and adjustment of supervisory board allowances. The document is short (953 characters) and primarily reports meeting decisions and personnel changes, not the full quarterly report itself. It also mentions that some proposals require shareholder meeting approval. This fits the category of Board/Management Information (MANG) because it announces changes in the supervisory board and related management decisions rather than providing comprehensive financial data or the full quarterly report.
2008-04-24 Chinese
2008年第一季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled "武汉马应龙药业集团股份有限公司 2008 年第一季度报告" which translates to Wuhan Mayinglong Pharmaceutical Group Co., Ltd. 2008 First Quarter Report. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management commentary for the first quarter of 2008. The report is unaudited as stated in the document. The length is substantial (15,000 characters) and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly). This matches the definition of an Interim / Quarterly Report (IR). It is not an announcement or a certification, but the actual report with substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. Q1 2008
2008-04-24 Chinese
第六届董事会第七次会议决议公告暨召开公司2007年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice of the resolutions passed at the sixth board meeting and the announcement of the upcoming 2007 Annual General Meeting (AGM) of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It includes details about the meeting date, location, agenda items such as approval of the 2007 annual financial report, profit distribution plan, appointment of auditors, and other governance matters. The document also contains procedural information for shareholders to attend and vote at the AGM. The text does not contain the actual annual report or financial statements but rather the announcement and notice of the AGM and related board resolutions. The document length is 2251 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2008-04-24 Chinese
有限售条件的流通股上市公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the listing of restricted tradable shares following a share reform plan. It includes specific information about the number of shares, shareholder commitments, changes in shareholding structure, and regulatory compliance confirmations from sponsoring institutions. The document is titled as an announcement and contains no financial statements or earnings data. It primarily informs about the listing of restricted shares and related shareholder information, which fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about share listing and shareholder structure changes, not a financial report or earnings release.
2008-03-25 Chinese
关于于个人股对价偿还撤销指定交易事宜的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Wuhan Mayinglong Pharmaceutical Group Co., Ltd. regarding the procedure for individual shareholders to cancel designated trading to facilitate share transfer and listing of restricted shares. It contains procedural instructions and contact information but no financial data, report content, or detailed financial analysis. The document is short (758 characters) and serves as a notification about a specific shareholder-related administrative process rather than a financial report or detailed filing. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a voting result or management change announcement. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories.
2008-03-14 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.